Mechanism of Induction of Endogenous Tumor Necrosis Factor in Ascites of Ovarian Cancer Patients by OK-432, A Streptococcal Preparation
- 1 January 1989
- journal article
- research article
- Published by Taylor & Francis in Immunopharmacology and Immunotoxicology
- Vol. 11 (1) , 33-53
- https://doi.org/10.3109/08923978909082141
Abstract
In four ovarian cancer patients with malignant ascites, 10 KE of OK-432 was intraperitoneally administered four times every other day for priming, and 40 KE of OK-432 in a single dose by the same route on day 13 for triggering. The changes in peripheral blood monocytes and intraperitoneal macrophages and the production of tumor necrosis factor (TNF) by peripheral blood mononuclear cells (PBMC) and ascitic lymphoid cells (ALC) were examined. In two of the four patients in whom TNF was induced in the ascites, the TNF production by PBMC and ALC was noted during priming, and after triggering, an increase in both the number of intraperitoneal macrophages and the TNF production by ALC was noted. In two other patients in whom TNF was not detected in the ascites, the ratio of intraperitoneal macrophages to ALC did not change throughout the whole period, and the TNF production by ALC was not augmented. These findings suggest that the priming administration of OK-432 can induce both intraperitoneal macrophages and peripheral blood monocytes into a primed state, and the triggering administration of OK-432 can increase the number of intraperitoneal OK-432-primed macrophages and induce TNF release from these cells.This publication has 9 references indexed in Scilit:
- ENDOGENOUS PRODUCTION OF TUMOR-NECROSIS-FACTOR IN NORMAL MICE AND HUMAN CANCER-PATIENTS BY INTERFERONS AND OTHER CYTOKINES COMBINED WITH BIOLOGICAL RESPONSE MODIFIERS OF BACTERIAL ORIGIN1987
- PHASE-I STUDY OF RECOMBINANT TUMOR-NECROSIS-FACTOR IN CANCER-PATIENTS1987
- Polypetide mediator networkNature, 1987
- Release of tumor necrosis factor (TNF) into mouse peritoneal fluids by OK-432, a streptococcal preparationImmunopharmacology, 1986
- Recombinant human tumor necrosis factor — II. Antitumor effect on murine and human tumors transplanted in miceInternational Journal of Immunopharmacology, 1986
- Recombinant human tumor necrosis factor — I. Cytotoxic activity in vitroInternational Journal of Immunopharmacology, 1986
- Therapeutic Effect of Endogenous Tumor Necrosis Factor on Ascites Meth A SarcomaImmunopharmacology and Immunotoxicology, 1986
- Use of monoclonal antibodies as sensitive and specific probes for biologically active human gamma-interferon.Proceedings of the National Academy of Sciences, 1984
- An endotoxin-induced serum factor that causes necrosis of tumors.Proceedings of the National Academy of Sciences, 1975